Point-of-care diagnostics market to hit $118.72B by 2030

The Business Research Company projects the global point-of-care diagnostics devices and equipment market will rise from $64.11 billion in 2025 to $71.62 billion in 2026, then reach $118.72 billion by 2030. Growth is being driven by mHealth adoption, outpatient care, chronic disease demand and a shift toward faster testing closer to the patient.

Why it matters: - Point-of-care testing is moving more diagnosis out of central labs and into clinics, homes and other care settings. - Faster results can support quicker treatment decisions, better patient flow and broader access to testing. - The market’s growth points to rising demand for portable, connected diagnostic tools across healthcare systems.

What happened: - The Business Research Company released its 2026 global market report on point-of-care diagnostics devices and equipment. - The report estimates the market will grow from $64.11 billion in 2025 to $71.62 billion in 2026. - The report forecasts the market will reach $118.72 billion by 2030. - North America was the largest regional market in 2025. - Asia-Pacific ranked second globally in 2025.

The details: - The 2026-2035 report highlights rising chronic disease prevalence, faster clinical decision-making needs, outpatient care growth, portable diagnostic adoption and preventive health focus as major growth drivers. - The report says demand will also be supported by home healthcare diagnostics, digital health integration, infectious disease screening, AI-supported diagnostic tools and remote patient monitoring. - Forecasted trends include rapid diagnostic tests, decentralized diagnostics, connected point-of-care platforms, more home testing and improved device usability and design. - Point-of-care diagnostics devices are designed to let healthcare professionals test patients at or near the point of care. - The devices are used for glucose and cholesterol monitoring, electrolyte and enzyme analysis, drug screening, infectious disease detection and pregnancy testing. - The report says immediate results help support faster clinical decisions and improve care pathways. - The report includes coverage of Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, the Middle East and Africa. - The 2026 report adds market attractiveness scoring, TAM analysis, company scoring matrix graphics and tables, Excel-based forecasting dashboards, market hotspots infographics, and updated graphics and tables. - The report is available with a free sample here. - The full report is available here.

Between the lines: - The strongest signal is the shift toward decentralized care, where testing needs to happen closer to the patient and faster than traditional lab workflows allow. - mHealth and connected devices are becoming part of the market’s core value proposition, not just add-ons. - The report’s focus on home testing and remote monitoring suggests point-of-care tools are expanding beyond clinical settings. - A cited PharmiWeb report from February 2025 said about 23% of healthcare interactions are expected to occur virtually, reinforcing the demand for remote-enabled diagnostics.

What’s next: - The market is projected to accelerate through 2030 as home diagnostics, digital health and AI-supported testing expand. - Further adoption of connected point-of-care platforms could broaden use cases across hospitals, outpatient centers and home care. - Regional growth opportunities are likely to remain concentrated in North America and Asia-Pacific while other regions build out testing infrastructure.

The bottom line: - Point-of-care diagnostics is evolving from a convenience tool into a core part of faster, more distributed healthcare delivery.